News

An industry-wide shift toward consumerism and value-based care reflects modern consumers’ desire for transparency around their healthcare coverage. In order to meet these heightened expectations, insurers must adapt and identify new ways to educate, engage and support members who are taking ownership of their options.

Managed Health Executive® editors Peter Wehrwein and Briana Contreras interviewed Kevin Ronneberg, M.D., for our “Meet the Board” podcast series. Ronneberg is vice president and associate medical director for health initiatives at HealthPartners, a nonprofit integrated healthcare delivery system headquartered in Bloomington, Minnesota. He has been on the MHE editorial advisory board since 2015.

Eli Lilly and UnitedHealth Group announced early last month that they are teaming up to conduct a “pragmatic” study of Lilly’s bamlanivimab, a monoclonal antibody developed as a treatment for COVID-19.

Collecting high-quality data is critical to addressing healthcare equity issues, according to Marcella Nunez-Smith, M.D., M.H.S., whom President-elect Joe Biden has chosen to lead a new White House task force on the issue.

Telehealth holds the promise of increasing access to care. But research findings concerning direct-to-consumer (DTC) telehealth, reported in JAMA Network Open last month, suggest that it might not be as simple as that.

In this week’s episode of Tuning In to the C-Suite podcast, MHE's Senior Editor Peter Wehrwein and Associate Editor Briana Contreras spoke with CEO of Syntellis Performance Solutions, Kermit Randa. In the discussion they talked about a recently released survey by Syntellis called the 2021 Healthcare Financial Trends Survey report, which highlights how finance leaders pivoted in 2020 and the way they will continue to evolve in 2021.

The COVID-19 pandemic in the U.S. has led to a significant drop in medical procedures as a result of individual and organizational precautions. This decrease, particularly during the first months of the pandemic, has and will continue to have severe implications for plans, providers, and patients.